
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£195.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£126.32
7D
-0.3%
1Y
13.8%
GSK
Market Cap: UK£76.9b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.32
7D
0.6%
1Y
38.3%
Haleon
Market Cap: UK£32.0b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.63
7D
-0.06%
1Y
-0.6%
Hikma Pharmaceuticals
Market Cap: UK£3.3b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.85
7D
0.2%
1Y
-18.3%